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Purpose: To perform usability testing of a binocular optical coherence tomography
(OCT) prototype to predict its function in a clinical setting, and to identify any
potential user errors, especially in an elderly and visually impaired population.
Methods: Forty-five participants with chronic eye disease (mean age 62.7 years) and
15 healthy controls (mean age 53 years) underwent automated eye examination using
the prototype. Examination included ‘whole-eye’ OCT, ocular motility, visual acuity
measurement, perimetry, and pupillometry. Interviews were conducted to assess the
subjective appeal and ease of use for this cohort of first-time users.
Results: All participants completed the full suite of tests. Eighty-one percent of the
chronic eye disease group, and 79% of healthy controls, found the prototype easier to
use than common technologies, such as smartphones. Overall, 86% described the
device to be appealing for use in a clinical setting. There was no statistically significant
difference in the total time taken to complete the examination between participants
with chronic eye disease (median 702 seconds) and healthy volunteers (median 637
seconds) (P ¼ 0.81).
Conclusion: On their first use, elderly and visually impaired users completed the
automated examination without assistance. Binocular OCT has the potential to
perform a comprehensive eye examination in an automated manner, and thus
improve the efficiency and quality of eye care.
Translational Relevance: A usable binocular OCT system has been developed that
can be administered in an automated manner. We have identified areas that would
benefit from further development to guide the translation of this technology into
clinical practice.
Introduction
Optical coherence tomography (OCT) imaging has
transformed ophthalmology.1,2 In 2011, it is estimated
that 20 million OCT examinations were performed
worldwide, more than the sum of all other ophthalmic
imaging combined.3 Although reasonably quick and
safe to perform, the costs involved with operating
OCT devices are not trivial.4,5 Commercial devices are
expensive to purchase, and the costs of associated
labor to capture the OCT scans are even greater.4 The
requirement for OCT and other imaging also places
increasing demand on ophthalmology clinics, with
fragmented patient pathways and often extended
waiting times.6,7 Clinic efficiency has recently been
reported to improve by stationing all necessary tests
for the visit in one location, minimizing the time
patients spend moving around and waiting.8
In this report, we explore a novel ‘‘binocular OCT’’
system (Envision Diagnostics Inc., El Segundo, CA)
that incorporates many aspects of the eye examina-
tion into one single patient-operated instrument.9
This device aims to improve both the efficiency and
quality of eye care while reducing the overall labor
and equipment costs. Automatic alignment of the
oculars to the user’s eyes allows patients to undertake
the full suite of tests, including ‘whole-eye’ OCT
imaging, without operator assistance. Paired with
‘smart technology’, such as customizable display
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screens to present information to the user, and voice
recognition to register user responses, the device also
performs a range of other ophthalmic diagnostic tests,
from visual acuity measurement to perimetry. The
binocular design of the device permits simultaneous
OCT image capture from both eyes, allowing OCT-
derived assessment of binocular functions, such as
pupillometry and ocular motility. With such a device,
it may thus be possible in the future to perform a
comprehensive, objective, quantitative ocular exami-
nation using a single instrument, and, additionally,
may have a role in telemedicine to transfer generated
data from remote locations.
While many such devices are capable of complet-
ing specific tasks, lack of ‘‘usability’’ prevents their
widespread adoption (i.e., device operations are not
easy to learn and remember, or are not efficient or
user-friendly).10,11 Moreover, devices that are difficult
to use or understand expose patients to clinical risk as
a result of human error during usage. Structured,
patient-centered, usability testing is essential to the
design, clinical validation, regulatory approval, and
widespread implementation of new medical devices.12
This is particularly the case for a putative binocular
OCT system – an automated device that will primarily
be used in visually impaired, often elderly, popula-
tions.
In this study, we perform prospective usability
testing of a binocular OCT prototype in a population
with chronic eye disease, and in healthy volunteers,
with a view to predicting likely function in a clinical
setting and identifying any potential user errors that
may expose the patient to clinical risk (EASE study –
ClinicalTrials.gov Identifier: NCT02822612). The
results of the study will facilitate an iterative process
of operating software and workflow modifications,
and thus aid the translational of this technology into
clinical practice.
Methods
Study Population
Forty-five participants with chronic eye disease
were prospectively recruited from glaucoma, retinal
disease, and strabismus clinics at Moorfields Eye
Hospital, London, UK. In addition, 15 healthy
volunteers with no self-reported history of ocular
disease were recruited as a control group. The sample
size was based on usability literature,13 and draft
guidance from the Food and Drug Administration
‘‘Human Factors’’ program.14 All participants were
required to have no significant hearing impairment
that would affect their ability to respond to instruc-
tions delivered by the device. A conversational level of
English was required for users to understand the
instructions, and to be able to communicate with the
device via an English language voice recognition
system (VRS). No participants were excluded based
on disease status to ensure our cohort consisted of
everyday users of eye care services. Therefore, ocular
comorbidities were permitted. Approval for data
collection and analysis was obtained from a UK
National Health Service Research Ethics Committee
(REC) (London-Central) and the study adhered to
the tenets of the Declaration of Helsinki.
Clinical Data Collection
Best-corrected visual acuity was initially measured
monocularly using Early Treatment Diabetic Reti-
nopathy Study (ETDRS) charts. For participants
with glaucoma, visual field mean deviation scores
were recorded from their most recent (,6 months)
SITA standard 24-2 examination on the Humphrey
Visual Field Analyzer (Carl Zeiss Meditec, Dublin,
CA). If worn, participants’ habitual refractive error
correction was measured using an automatic lens-
meter (Grafton Optical, Berkhamsted, UK). Both
acuity and habitual refractive error were inputted into
custom software connected to the binocular OCT
device.
Prototype Binocular OCT Technical
Specifications
The binocular OCT prototype was a similar size as
other commercial OCT systems in use today. It was
mounted on a motorized base that allows users to
adjust the instrument height. It was a Class 1 laser
system that has two internal full color displays and
one swept-source OCT laser (Axsun Technologies,
Billerica, MA) centered at 1060 nm that enables OCT
imaging of both eyes. The laser power was limited to
the lowest power allowed by Class 1 limits for single
pulse, pulse train, and average power across 30,000
seconds of use for a conservative duty cycle estimate
of 66% and subtended beam angle of 1.5 mrad.
Custom optics on independent linear motion stages
were used to direct and focus light into the subject’s
eyes. A hardware VRS (Sensory, Inc., Santa Clara,
CA) and a text-to-speech module (TextSpeak, Inc.,
Westport, CO) were used for communications with
the participant. The prototype was connected to an
external central computer system that, along with
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internal custom electronics, handles data processing
and output.
Binocular OCT Examination
Prior to examination a spherical equivalent of the
participant’s habitual refractive correction was re-
motely placed within the prototype device. Without
prior training, participants then underwent automat-
ed binocular OCT examination, under direct supervi-
sion by a study investigator (RC). Instructions for the
examination and individual tests were delivered in an
automated manner using TextSpeak and a speaker
system built into the prototype. All instructions were
spoken in a female British English voice. Participants
were asked to listen carefully to the instructions and
respond verbally when asked to do so by the device.
Participants were advised that the examination would
consist of several tests and that the device will inform
them when the examination has concluded. All
examinations were video recorded with participant
consent.
The order of testing is listed below. While 1 and 2
were performed simultaneously on both eyes, tests 3,
4, 5, and 6 were performed on the left eye first
followed by the right eye. This order was arbitrary
and preset for this device.
Test 1: Introduction to the Examination and Initial
Ocular Alignment
The device instructed the user to place their head in
the mask, and respond ‘‘ready’’ to begin examination.
The mask incorporated a nose rest and a disposable
forehead rest. Disposable safety goggles made of
American National Standards Institute (ANSI) Z97.1
compliant polycarbonate was placed on the interface
for protection from the moving optics within the
device. Once the user was comfortable and ready to
begin, the device presented a circular fixation target
covering a 2.58 field on the retina to eye with better
acuity. The device then proceeded by moving the
optics of the device to align with the user’s eyes. Real-
time segmentation of the cornea and iris planes
provided the device with simultaneous feedback on
accurate alignment (Fig. 1). Ocular alignment was
automatically reassessed prior to each individual test
to ensure the user was still in the correct position. The
device was able to recognize when the user was
leaning away from the mask or not fixating – in these
cases, the machine provided the user with additional
instructions to adjust their head position, or to
remind them to look at the fixation target. The optics
within the device were simultaneously adjusted to
regain alignment before proceeding with the next test.
Test 2: Whole-Eye Swept-Source OCT Imaging
‘Whole-eye’ imaging, as defined by recent litera-
ture,15,16 was the first diagnostic test to be performed.
The user was instructed to look at a central fixation
target, presented to the eye with better acuity. The
following OCT images were captured from both eyes
simultaneously: (1) anterior segment OCT imaging –
128 raster scans consisting of 1350 A-scans each
covering an area of 16 3 16 mm of the anterior
segment, and one horizontal and one vertical aver-
aged scan, (2) posterior segment OCT imaging – 128
raster scans consisting of 1350 A-scans each covering
an area of 14 3 14 mm of the retina centered on the
macula, and one horizontal and one vertical averaged
scan, and (3) vitreous OCT imaging – raster scan of
128 slices imaging up to an inner depth of 8 to 10 mm
from the retina, and one horizontal and one vertical
averaged scan. All averaged scans were generated
Figure 1. Real-time segmentation of optical coherence tomography (OCT) images of the anterior cornea and pupil center. Images are
captured in the vertical (A, C) and horizontal (B, D) meridians of both eyes. Segmentation aids accurate alignment of the optics within the
device to the user’s eyes.
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from 16 B-scans through the central meridians (Fig.
2).
Test 3: Ocular Motility
This examination was performed with one eye
fixating at a time, while capturing simultaneous OCT
images of the vertical and horizontal planes of the
anterior segments of both eyes. A fixation target was
presented in primary position (center) and eight
positions of gaze 48 from center (west, northwest,
north, northeast, east, southeast, south, southwest).
The coordinates of the position of the anterior
segment of both the fixating and nonfixating eyes
could subsequently be mapped to detect the presence
of heterophorias, heterotropias, and abnormal eye
movements.
Test 4: Visual Acuity
Visual acuity was assessed monocularly. Each eye
was presented with single ETDRS targets on the
display screen. The device instructed the user to
verbally report the letter they can see or respond ‘‘I
don’t know’’ if they were unable to discern it.
Responses were registered using a VRS with an
automated threshold algorithm17 used to determine
final acuity. For each presented letter, the user was
given a window of 10 seconds to respond. The device
presents the next largest visual acuity target if the
response is incorrect or not heard. In the current
system, the size of the largest visual acuity targets
range from 20/16 to 20/800. (See Supplementary
Video S1).
Test 5: Suprathreshold Perimetry
A 28 3 28 high-contrast, square-wave grating
stimulus was randomly presented in the same eight
peripheral subfields as tested in the motility exam.
Participants were instructed to focus on the central
fixation target and respond ‘‘yes’’ when the stimulus
was visible. Users have a timeframe of 2 seconds to
respond on top of a random time delay of up to 3
seconds before the next stimulus is presented.
Test 6: Pupillometry
Pupil reactions were assessed using simultaneous
OCT capture of the anterior segments including the
iris plane. Each eye was stimulated independently and
sequentially with a single, bright, 250-ms flash of
white light. B-scan recordings are captured at regular
intervals of 350 ms prior to stimulation and 4000 ms
post-stimulation. Measurements of the pupil circum-
ference could subsequently be calculated to identify
pupil abnormalities and relative afferent pupillary
defects (Fig. 3).
Test Duration and Completion Rates
The following information was collected during
and after the examination:
 Overall examination time;
 Time needed to complete individual diagnostic
tests;
 Examination completion rates for the whole
examination and for each individual diagnostic
test; and
Figure 2. Averaged OCT B-scan images acquired using the
binocular OCT prototype in a healthy volunteer. Anterior and
posterior segment images are captured of both eyes
simultaneously.
Figure 3. Automated quantitative pupillometry using the
binocular OCT prototype. (A) Pupils of both eyes dilated
immediately prior to stimulation. (B) Pupils at maximum
constriction after controlled flash of light presented to the right
eye. Note the anisocoria – the left pupil does not constrict equally
to the right pupil. In post-processing, the presence and extent of
pupillary defects can be calculated using OCT-derived
measurements of the pupil circumference.
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 Observed user and device errors that may lead to
the generation of erroneous examination ﬁndings.
Interview and Questionnaire
A pretest interview was conducted prior to
binocular OCT examination to gauge participants’
levels of experience with common technologies such
as computers, smartphones, the Internet, and email.
Immediately after the examination, a short debriefing
discussion was conducted. Participants were asked to
rate the ease of the examination in comparison to the
technologies they commonly use. Subjective ease of
use, duration, and appeal were rated on a 5-point
Likert scale. Verbatim comments were also recorded.
Patient and Public Involvement (PPI)
Prior to study setup, a patient focus group of 10
contributors was convened to assist with informing
the design and implementation of the study. A second
group of nine contributors (including 4 people from
the first focus group) was convened after study
completion to advise on dissemination of preliminary
results, and hence provide discourse for recommen-
dations to improve the device to aid its translation
into a clinical setting. The events lasted for approx-
imately 3 hours. The PPI team from the National
Institute for Health Research (NIHR) Biomedical
Research Centre at Moorfields Eye Hospital facili-
tated the discussions.
Engaging end-users is essential for all stages of the
clinical validation of health technologies.18,19 The
inclusion of PPI was particularly relevant for a self-
operated binocular OCT device intended for use in
elderly and visually impaired populations to identify
user requirements while the device was in early-stage
development. The recommendations of participants,
patients, and the public will guide the modification of
the interface and workflow of the binocular OCT
system.
Results
Patient Demographics
Thirteen participants had glaucoma only (12 with
primary open angle glaucoma [POAG], 1 with
glaucoma secondary to hypertensive uveitis). Fourteen
had strabismus only (7 with esotropia, 6 with
exotropia, and 1 with hypertropia). Fourteen had
bilateral retinal disease only (including 8 with age-
related macular degeneration [AMD], 4 with diabetic
macular edema, 1 with central serous retinopathy, and
1 with retinal vein occlusion with cystoid macular
edema). Four participants had ocular comorbidities:
two with bilateral POAG and AMD; one had
unilateral POAG and a symptomatic epiretinal mem-
brane in the fellow eye; and one had bilateral POAG
and congenital convergent strabismus. Table 1 presents
their clinical and demographic characteristics.
Table 1. Clinical and Demographic Characteristics
Age,
Mean 6 SD
(Range) (y)
Visual Acuity
Better Eye,
Mean 6 SD
(Range)
(logMAR)
Visual Acuity
Worse Eye,
Mean 6 SD
(Range)
(logMAR)
Visual Fields
Mean
Deviation
Better Eye,
Mean 6 SD
(dB)
Visual Fields
Mean
Deviation
Worse Eye,
Mean 6 SD
(dB)
Refractive Error
Spherical
Equivalent,
Mean 6 SD
(DS)
Chronic eye disease (n ¼ 45)
Glaucoma
(n ¼ 13)
64.1 6 14.7
(27–83)
0.10 6 0.12
(0.08 to 0.24)
0.20 6 0.12
(0.00–0.42)
6.31 6 8.17 11.75 6 10.41 0.54 6 0.76
Retinal disease
(n ¼ 14)
71.0 6 11.4
(50–88)
0.35 6 0.24
(0.02–0.84)
0.68 6 0.34
(0.24–1.30)
0.89 6 2.21
Strabismus
(n ¼ 14)
50.8 6 19.1
(23–74)
0.04 6 0.08
(0.20 to 0.10)
0.24 6 0.27
(0.10 to 0.78)
0.54 6 2.19
Ocular
comorbidities
(n ¼ 4)
70.5 6 8.0
(61–81)
0.24 6 0.42
(0.10 to 0.78)
0.63 6 0.53
(0.1 to 1.18)
7.59 6 6.86 11.28 6 5.81 1.11 6 1.80
Healthy controls
(n ¼ 15)
53.1 6 11.2
(30–67)
0.01 6 0.14
(0.16 to 0.30)
0.02 6 0.15
(0.16 to 0.30)
0.29 6 1.26
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Binocular OCT Examination
All participants completed the full suite of tests
using the binocular OCT device without assistance.
The Shapiro-Wilk test revealed that overall examina-
tion times were not normally distributed. The median
time to complete the full suite of diagnostic tests on
the binocular OCT prototype was 702 seconds
(interquartile range [IQR]: 627–845 seconds) in the
group with chronic eye disease, and 638 seconds
(IQR: 572–821 seconds) in the healthy control group.
There was no significant difference in the time taken
to complete the full suite of tests on the binocular
OCT system between the two groups (P ¼ 0.30,
Mann-Whitney U test). Similarly, there was no
statistical difference in the overall examination time
between participants with glaucoma, strabismus,
retinal disease, ocular comorbidities, and healthy
volunteers (P ¼ 0.81, Kruskal-Wallis; Fig. 4).
Individual Diagnostic Test Times
Test times for each of the diagnostic tests are
presented in Table 2. These values include the time
spent reassessing and realigning the optics of the
device with the participant’s eyes prior to each test (if
required). There was no statistically significant
difference between the chronic eye disease group
and the healthy volunteers in the time taken to
complete the individual tests, except in the case of
visual acuity measurement (P¼0.004), where diseased
eyes took longer (median 168 seconds, compared with
133 seconds for healthy volunteers).
Major Examination Components
To determine how much time the prototype spent
on various activities, the examination times were
dissected further into four major exam components as
indicated in Figure 5 including (1) audio instructions
(the machine speaking to the user), (2) voice responses
(the machine waiting for and interpreting voice input
from the user), (3) OCT imaging (amount of time
spent gathering OCT data for the tests), and (4)
component movements (including respositioning of
the motors and other optical components within the
machine to maintain optical alignment with the user’s
eyes).
The device spent a median time of 178 seconds
providing instructions to the participant (range 130–
367 seconds). The time taken to provide the standard
instructions was fixed at 130 seconds for each exam.
The remainder of the time was spent providing
additional instructions when the device recognized
Figure 4. Box plots showing total examination time for each
group. The horizontal lines within each box represent the median
for each group; the ends of the boxes are the upper and lower
quartiles, and the whiskers represent minimum and maximum
values. The data for each individual participant is included as
peripheral scatter plots.
Table 2. Time Taken to Complete Individual Diagnostic Tests
Chronic Eye Disease
(n ¼ 45)
Healthy Controls
(n ¼ 15) Mann-Whitney U Test
Median Time (s) and IQR Median Time (s) and IQR P Value
Introduction and
ocular alignment
94 (55–125) 80 (64–101) 0.500
OCT imaging 159 (149–179) 155 (151–169) 0.932
Ocular motility 78 (66–96) 72 (64–85) 0.591
Visual acuity 168 (138–196) 133 (110–152) 0.004*
Suprathreshold perimetry 122 (111–137) 113 (106–170) 0.620
Pupillometry 69 (54–89) 67 (62–106) 0.394
Overall 702 (627–845) 637 (572–821) 0.302
There was no statistically significant difference between the two groups, except for the visual acuity test.
* Significant at P , 0.05.
6 TVST j 2017 j Vol. 6 j No. 4 j Article 16
Chopra et al.
that the user was not fixating or keeping their eyes
open. In these cases, the device would automatically
attempt to find their eyes and would give them
instructions to look at the fixation target.
A median time of 163 seconds was spent on voice
recognition (range, 116–251 seconds). Voice recogni-
tion was only required for visual acuity and perimetry
at present, therefore examinations that spent longer
on voice recognition indicate that a longer time was
spent on these two sections of the examination.
The device spent an average of 139 seconds
performing OCT imaging (range, 125–139 seconds)
during the entire exam. This was a fairly constant
amount of time required to perform ‘whole-eye’
imaging.
An average of 122 seconds was spent moving optics
within the machine per exam (range, 66–250 seconds).
This was strongly correlated with the amount of time
spent providing instructions to the participant (Pear-
son’s correlation r ¼ 0.82, P , 0.001). Examinations
where additional instructions were provided also
required simultaneous repositioning of the optics.
Observed Errors
As presented in Table 3, the majority of examina-
tions generated usable data. Both device and user
errors affected the quality of data produced. OCT
imaging was classified as ‘ungradable’ if the OCT
scans were poor quality (i.e., if there were severe
artifacts or generalized reductions in signal strength
to the extent that major interfaces could not be
identified). Poor quality posterior segment and
vitreous images were captured if the participant
blinked during image capture, or if the position of
the eye was incorrect. One healthy volunteer had their
eyes closed throughout the imaging test and no
anterior segment imaging data were acquired. Good
quality anterior segment images were obtained for all
other participants.
Motility exams were classified as ungradable if the
user did not fixate on the target displayed in the
various positions of gaze. The motility test currently
consists of a fixation target that appears in different
locations, rather than requiring the user to ‘fix and
follow’. Unsurprisingly, we found that participants
with advanced POAG were not able to detect the
target when presented in a scotoma. Similarly,
participants with poor visual acuity were unable to
see the fixation target due to its low contrast. Other
observed errors included one participant with POAG
misinterpreting the motility test for a visual field test
and therefore not following the motility target.
Data for visual acuity and perimetry exams were
classified as ungradable if the participant did not
respond, and thus a measurement could not be
generated. Three participants did not verbally re-
spond when required during the visual acuity test.
Table 3. Number of Examinations that Generated
Gradable Data
Chronic Eye Disease
(n ¼ 45)
Healthy Controls
(n ¼ 15)
N (%) N (%)
Anterior segment imaging
OS 45 (100) 14 (93.3)
OD 45 (100) 14 (93.3)
Posterior segment imaging
OS 38 (84.4) 13 (86.7)
OD 42 (93.3) 13 (86.7)
Vitreous imaging
OS 38 (84.4) 13 (86.7)
OD 42 (93.3) 13 (86.7)
Motility
OS fixating 21 (60.0) 14 (93.3)
OD fixating 26 (74.2) 14 (93.3)
Visual acuity
OS 42 (93.3) 15 (100)
OD 45 (100) 15 (100)
Suprathreshold perimetry
OS 43 (95.6) 15 (100)
OD 44 (97.8) 15 (100)
Pupillometry
OS flash 39 (86.7) 13 (86.7)
OD flash 41 (91.1) 13 (86.7)
Figure 5. Scatter plots illustrating the time spent on the major
exam components for all participants. The horizontal lines
represent the median time, Q2, for each component.
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Similarly, only one participant did not respond during
perimetry. We also observed errors in the accuracy of
the voice recognition system. The sensitivity of the
VRS was calculated by comparing the participant’s
verbal response to the response interpreted by the
device. Average sensitivity measured as 64% overall
for all 60 participants (range, 12.5%–100%). This
appeared to be related to the system misinterpreting
the user (e.g., ‘‘A’’ heard when the user responds ‘‘K’’
in the acuity test), or if the user responded with
multiple answers (e.g., ‘‘Y or V’’), or attempted to
change their answer.
Pupillometry values were classified as ungradable
if the pupil response data could not be generated from
the examination. Errors were observed if the user
blinked during the test or looked away from the
central fixation target so that the pupil was occluded.
Interview
Eighty-two percent of our cohort with chronic eye
disease and 93% of healthy volunteers used common
technologies, such as computers and smartphones at
least a few times per week. All of these participants
regularly used the Internet and email communication.
Four participants, including one healthy volunteer,
never used these technologies.
Eighty-one percent of participants with chronic eye
disease and 79% of healthy volunteers subjectively
found the binocular OCT system easier to use than a
computer or smartphone. Table 4 presents subjective
ratings for ease of use, appeal, and duration. Seventy-
eight percent of participants with chronic eye disease
and 87% of healthy volunteers rated the binocular
OCT 4 or 5 on ease of use (1¼ very difficult, 5¼ very
easy).
Fifty-eight percent of chronic eye disease partici-
pants and 54% of healthy volunteers rated 4 or 5 on
duration of test (1 ¼ very long time, 5 ¼ very short
time). Overall, 86% found the device appealing to use
in a clinical setting. There was no significant
correlation between age and subjective ratings for
ease of use, duration, or appeal. There was however a
significant correlation between subjective ratings for
ease of use and duration (P , 0.001, Spearman’s
rank) and ease of use and appeal (P , 0.001) in the
overall cohort. Interestingly, we found no significant
correlation between overall examination time and
subjective ratings for ease of use, appeal, or duration.
All four subjects that were unfamiliar with common
technologies rated the examination 4 or 5 on ease,
appeal, and duration.
Verbatim comments revealed that participants felt
the device delivered clear instructions and was easy to
use. Of participants, 37% commented that the device
Table 4. Subjective Ratings for Binocular OCT Examination, Rated on a 5-Point Likert Scale
Chronic Eye Disease (n ¼ 45) Healthy Controls (n ¼ 15)
N (%) Mean Age and SD (y) N (%) Mean Age and SD (y)
Ease of use
5 (very easy) 20 (44.4) 63.80 6 12.63 6 (40.0) 52.33 6 12.29
4 15 (33.3) 58.07 6 21.75 7 (46.7) 52.43 6 11.77
3 8 (17.8) 65.75 6 17.07 1 (6.7) 50
2 1 (2.2) 67 1 (6.7) 65
1 (very difficult) 1 (2.2) 80 0 (0.0) -
Duration
5 (very short time) 15 (33.3) 66.13 6 10.93 2 (13.3) 55.00 6 7.07
4 11 (24.4) 63.27 6 17.78 6 (40.0) 53.83 6 13.48
3 17 (37.8) 60.29 6 20.13 7 (46.7) 51.86 6 11.29
2 2 (4.4) 53.50 6 31.82 0 (0.0) -
1 (very long time) 0 (0.0) - 0 (0.0) -
Appeal
5 (very appealing) 21 (46.7) 66.29 6 11.52 8 (53.3) 50.75 6 14.08
4 18 (40.0) 59.55 6 18.23 5 (33.3) 55.00 6 6.00
3 3 (6.7) 40.33 6 26.63 2 (13.3) 57.50 6 10.61
2 2 (4.4) 77.50 6 4.94 0 (0.0) -
1 (very unappealing) 1 (2.2) 80 0 (0.0) -
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headrest and mask interface was physically uncom-
fortable. Participants with poor acuity found the
fixation target to be unclear.
PPI Recommendations
Generally, contributors to the focus group felt that
performing their own eye examination facilitated
more control over their care. They felt confident that
the generation of robust, standardized data from
smart devices, such as the binocular OCT system
would aid monitoring of eye disease. The group
welcomed the potential significant reduction in
waiting time, and felt that the automated eye
examination would benefit both patients and clini-
cians. They highlighted the importance of feedback to
patients during automated testing to reassure that the
tests were being correctly completed. Concerns were
also raised regarding the concept of automation and
whether patients would still have an opportunity to
interact with their clinician if the device was
implemented in clinics.
Discussion
In this study, we performed prospective usability
testing of an early binocular OCT prototype in a
population of study participants with chronic eye
disease, as well as in healthy volunteers. To our
knowledge, this is the first system that can perform a
comprehensive eye examination – with functional and
diagnostic testing in addition to conventional OCT
structural imaging – in an end-to-end, automated
manner.
Historically, eye examinations in hospital eye clinics
have been fragmented, inefficient, and costly.4–6,8 The
binocular OCT prototype combines many routine tests
into one single instrument, with the aim of improving
the speed and efficiency of patient flow, in addition to
providing reproducible and quantitative data for
several aspects of the eye examination. Designed as
an automated, patient-operated device, usability test-
ing is indispensable to predict the likelihood of future
successful implementation in eye clinics. Moreover,
usability testing can identify potential user and device
errors, and thus facilitate continued improvement of
the device in an iterative process.
Our cohort of first time users was able to complete
the full suite of tests using the binocular OCT
prototype without any previous training and without
any assistance during the examination. Participants
commented that the device provided ‘‘clear instruc-
tions’’ and was ‘‘easy to use.’’ The majority of our
cohort was familiar with operating common technol-
ogies, such as computers and smartphones, and found
the prototype to be easier to use in comparison.
However, those unfamiliar with technology also rated
the device highly on ease of use.
We found that the subjective ratings for ease of use
and appeal of the device correlated with ratings for
test duration. Participants who perceived the exami-
nation took a short time, rated the ease and appeal
more positively. However, subjective ratings for
duration did not correlate with the total examination
time. We observed no significant difference in the
total examination time between participants with
chronic eye disease and healthy controls. Overall,
the median time taken to complete the examination
was 702 seconds (11.7 minutes) for participants with
chronic eye disease and 638 seconds (10.6 minutes) for
healthy controls. By comparison, Callaway et al.8
reported a mean clinic time of 28.8 minutes for
patients to undergo technician work-up (including
history-taking and visual acuity measurement), and
acquisition of retinal OCT in the photography suite.
In many real-world settings, mean diagnostic testing
time is likely to greatly exceed this, particularly in
public healthcare settings, which are often overbur-
dened and under resourced. Thus, binocular OCT
examination is likely to be more efficacious than
current workflows as patients undergo all tests in one
location in an automated manner, reducing the time
patients spend travelling through the eye clinic.
Nonetheless, an important aspect of iterative usability
testing is to try to identify examination components
that can be further improved in terms of speed.
A small proportion of examinations generated
ungradable data. In the case of visual acuity and
perimetry measurements, this was a consequence of the
user not responding verbally when required. This
occurred more frequently for the visual acuity exam
in the left eye – the first eye to be tested that required a
verbal response. A more complete set of results was
obtained for the right eye in these users, and for the
subsequent perimetry exam. This may be explained by
a learning effect, where the user subsequently under-
stood that the task required a verbal response. As
similarly reported in perimetry literature, increased
exposure to the device on repeated testing is likely to
yield more reliable results and improve all aspects of
usability.20 Similarly, we found that the motility exam
generated more reliable data when the second eye was
fixating. Ungradable data for motility exams was more
prevalent in users with chronic eye disease. This was
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likely related to poor visual acuity or reduced visual
fields, affecting the ability to discern the motility target.
In future iterations, this test could be improved by
using a high luminance ‘fix and follow’ target.
We obtained good quality automated OCT images
of the anterior segment in all except one participant,
and good quality posterior segment and vitreous
images in the majority of participants. Given our
aging populations, and the increasing prevalence of
ocular comorbidities, the collection of objective,
quantitative OCT data for the whole-eye is likely to
be valuable for longitudinal monitoring and detection
of eye disease. In addition, the ability to derive OCT
measurements of vitreous activity could have appli-
cations in monitoring vitritis.21 The quality of OCT
data generated for both whole-eye imaging and
pupillometry was affected by ocular misalignment –
a consequence of the user moving their eyes, poor
fixation, or blinking during the examination. Our
prototype is susceptible to these errors due to the
relatively long image acquisition time to complete
simultaneous whole-eye OCT (mean 139 seconds).
With advances in swept-source OCT laser technology,
image acquisition speed is likely to improve in further
iterations of the device, rendering the device less
vulnerable to artifacts. The quality of OCT imaging,
in particular, posterior segment and vitreous imaging
also appeared to be affected by large angle strabis-
mus. In these cases, the images for the fixating eye
were acceptable, whereas the OCT lasers were unable
to image directly through the pupil in the nonfixating
heterotropic eye due to the large angle between the
pupil plane and the direction of the laser.
To be functional as an automated and interactive
device, it is essential that the system is responsive to
the user. In the current binocular OCT prototype, this
encompasses elements such as voice recognition. In
our study, the sensitivity of the VRS was only 64%.
This is likely related to the wide variation in
articulation, volume, and regional accents of our
cohort. Although the examination was undertaken in
a quiet room, background noise from the machine
itself may have impacted the response heard by the
system. As voice recognition technology becomes
more sophisticated, the error rate is likely to reduce,
but may not be eliminated. Other interactive features,
such as registering responses via buttons, in a similar
way to many current visual field tests, may be more
appropriate for some functional tests. In some
populations (e.g., pediatrics), where responses may
be unreliable, objective tests using OCT imaging to
track responses may be more suitable. For example,
visual acuity could be measured by presenting
optokinetic stimuli to the user while simultaneously
tracking the movement of the fovea on OCT.
Dissecting the examinations further into the time
taken to complete major exam components, we found
that delivering instructions took the greatest amount
of time, especially in exams where the user was
repeatedly reminded to fixate. Participants comment-
ed that the central target was unclear – improving its
intensity is likely to improve fixation. Although
participants found the instructions to be ‘‘clear,’’
articulating instructions in a more succinct manner
will reduce the overall examination time – this is one
aspect that is particularly likely to benefit from
patient and public input.
The main advantage of human operators is the
immediate recognition of the discussed errors and
artifacts, whereas fully automated devices will require
an inherent feedback mechanism to assess the quality
of the generated data. This is important for deter-
mining whether tests need to be repeated, or if the
user requires further or specialist examination beyond
the scope of the device. This was also one concern
highlighted at our PPI event. Reassurance could be
provided to the patient via a visual or audio notifica-
tion, or indirectly through feedback from a technician
working in the clinic; however, this would be most
beneficial in parallel with an in-built tool for
simultaneous quality control.
User requirements encompass more than clinical
effectiveness, and the ergonomics of the device must
also be considered. Many of our participants com-
mented that the device interface was physically uncom-
fortable. Assessing the needs of multiple types of users
is essential to encourage continued use of medical
devices.10 For late-stage prototypes, extensive ergono-
mic testing will be essential prior to commercial release.
In summary, the results of our usability study, and
related focus group testing, make it clear that patients
are receptive to the concept of an automated eye
examination. To be attractive to users, easy to use,
and effective at performing automated eye examina-
tions, the system will need to be quick, responsive,
and comfortable. For a system that aspires to be fully
automated (i.e., operated by the patient without
assistance), ongoing patient and public input will be
essential to guide the design of the device. Further
studies will be required to validate the diagnostic
accuracy of each of the tests offered by the system.
Once established, binocular OCT will offer objective,
quantifiable information about almost every aspect of
the eye examination and has the potential to
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supersede many traditional but flawed testing meth-
ods. It is unlikely that the automated eye examination
will be suitable for use in all patients. However, if
such a system can replace some aspects of the eye
examination, workflows and waiting times are likely
to improve, costs are likely to reduce, and clinicians
will be able to devote more time to patient care.
Ultimately, this will improve the overall experience
for both the patient and the clinician, and improve the
overall quality of patient care.
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